Serum free fatty acid biomarkers of lung cancer.
暂无分享,去创建一个
E. Mascha | P. Mazzone | D. Sessler | A. Kurz | Jinbo Liu | J. Cata | M. Bauer | Maria Bauer
[1] D. Hess,et al. Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells , 2011, Experimental biology and medicine.
[2] H. Sox. Screening for lung cancer with chest radiographs. , 2011, JAMA.
[3] Sang-Gu Hwang,et al. Phospholipase A 2 Activity of Peroxiredoxin 6 Promotes Invasion and Metastasis of Lung Cancer Cells , 2010 .
[4] V. Rogiers. Stability of the long chain non-esterified fatty acid pattern in plasma and blood during different storage conditions. , 1978, Clinica chimica acta; international journal of clinical chemistry.
[5] R. DuBois,et al. Measurement of eicosanoids in cancer tissues. , 2007, Methods in enzymology.
[6] D. Steinhilber,et al. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. , 2011, The Journal of clinical investigation.
[7] A. Pozzi,et al. EET signaling in cancer , 2011, Cancer and Metastasis Reviews.
[8] Massimo Triggiani,et al. Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2 , 2010, The Journal of Immunology.
[9] M. Underwood,et al. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer , 2010, Thorax.
[10] Z. Shi,et al. Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A2 and peroxisome proliferator-activated receptor gamma , 2011, Molecular and Cellular Biochemistry.
[11] M. Weiser-Evans,et al. Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis , 2011, PloS one.
[12] T. Haas,et al. Endothelial cell 13-HODE synthesis and tumor cell endothelial cell adhesion. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.
[13] G. Mills,et al. Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.
[14] Jeffrey S. Morris,et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Paige,et al. HPLC quantification of 5-hydroxyeicosatetraenoic acid in human lung cancer tissues. , 2009, Biomedical chromatography : BMC.
[16] Charles Pound,et al. Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics , 2012, PloS one.
[17] I. Kudriavtsev,et al. [Ability of the neoplastic tissue to biosynthesize 12- and 15-hydroxyeicosatetraenoic acids as criterion of metastasizing activity of human lung neoplasms]. , 1998, Biulleten' eksperimental'noi biologii i meditsiny.
[18] Sang-Gu Hwang,et al. Phospholipase A2 Activity of Peroxiredoxin 6 Promotes Invasion and Metastasis of Lung Cancer Cells , 2010, Molecular Cancer Therapeutics.
[19] T. Moody,et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. , 1996, The Journal of clinical investigation.
[20] S. Hazen,et al. The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo. , 2006, Life sciences.
[21] T. Nikkari,et al. Stability of plasma fatty acids at -20 degrees C and its relationship to antioxidants. , 1986, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[22] C. Holland,et al. Peroxisome Proliferator–Activated Receptors Modulate Proliferation and Angiogenesis in Human Endometrial Carcinoma , 2011, Molecular Cancer Research.
[23] M. Murakami,et al. Cellular Distribution, Post-translational Modification, and Tumorigenic Potential of Human Group III Secreted Phospholipase A2* , 2005, Journal of Biological Chemistry.
[24] C. Gatsonis,et al. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .
[25] K. Honn,et al. Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. , 1989, Cancer research.
[26] J. Bronstein,et al. Increases in 13-hydroxyoctadecadienoic acid dehydrogenase activity during differentiation of cultured cells. , 1993, Carcinogenesis.
[27] M. Notarnicola,et al. A significant role of lipogenic enzymes in colorectal cancer. , 2012, Anticancer research.
[28] E. Maser,et al. Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential. , 2012, Recent patents on anti-cancer drug discovery.
[29] Navdeep S. Chandel,et al. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.
[30] D. Rose,et al. Effects of dietary menhaden oil, soy, and a cyclooxygenase inhibitor on human breast cancer cell growth and metastasis in nude mice. , 1997, Nutrition and cancer.
[31] E. Z. Hirsch,et al. Stability of fatty acids in hyperlipoproteinemic plasma during long-term storage. , 1976, Clinical chemistry.
[32] F. Snyder,et al. Fatty acid biosynthesis and dietary regulation in pulmonary adenomas. , 1976, Archives of biochemistry and biophysics.
[33] B. Liu,et al. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. , 1994, Cancer research.
[34] S. Zick,et al. Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer , 2011, Cancer Prevention Research.
[35] I. Kudriavtsev,et al. [Synthesis of arachidonic acid cascade eicosanoids in tumors of various histogenesis in mice]. , 1995, Vestnik Rossiiskoi akademii meditsinskikh nauk.
[36] L. Qiu,et al. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[37] M. Weiser-Evans,et al. Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. , 2009, Cancer research.
[38] Marshall W. Anderson,et al. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules , 2011, BMC Cancer.
[39] J. Tímár,et al. Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis. , 1992, Prostaglandins.
[40] R. Nemenoff. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis , 2012, Oncoimmunology.
[41] J. Gohagan,et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. , 2011, JAMA.
[42] D. Hallahan,et al. Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis , 2010, Journal of the National Cancer Institute.
[43] H. Horstmann,et al. Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the localization of cathepsin B and cathepsin L in human lung tumor cells. , 1997, European journal of cell biology.
[44] N. Samadi,et al. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine‐induced migration of human breast cancer and melanoma cells , 2009, Molecular carcinogenesis.
[45] A. Lichtenstein,et al. Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions[S] , 2010, Journal of Lipid Research.
[46] Baolin Zhang,et al. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF. , 2007, Cancer research.
[47] G. Bonsel,et al. Can whole-blood samples be stored over 24 hours without compromising stability of C-reactive protein, retinol, ferritin, folic acid, and fatty acids in epidemiologic research? , 2005, Clinical chemistry.
[48] W. Glasgow,et al. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. , 2004, Neoplasia.
[49] S. Im,et al. PTEN/MAPK pathways play a key role in platelet‐activating factor‐induced experimental pulmonary tumor metastasis , 2012, FEBS letters.
[50] Gordon Mills,et al. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. , 2007, Methods in enzymology.
[51] J. J. Moreno. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. , 2009, Biochemical pharmacology.
[52] D. Rose,et al. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. , 1994, Cancer research.
[53] P. Bach,et al. Reduced lung-cancer mortality with CT screening. , 2011, The New England journal of medicine.
[54] R. A. Igal. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. , 2010, Carcinogenesis.
[55] Rebecca Sutphen,et al. Lysophospholipids are potential biomarkers of ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.